Legend:
CC = Baltimore Convention Center,
H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
140 * !
Mon, 7/31/2017,
10:30 AM -
12:20 PM
CC-314
The Challenges and Advantages of Utilizing Bayesian Statistical Methodology in Extrapolation of Adult Use Data to Pediatric Study Designs and Evaluation — Invited Papers
Biopharmaceutical Section , Section on Bayesian Statistical Science , Biometrics Section
Organizer(s): Yodit Seifu, Ferring Pharmaceuticals
Chair(s): Yodit Seifu, Ferring Pharmaceuticals
10:35 AM
Bayesian Statistics in Extrapolation for Pediatric Trials
—
Freda Cooner, FDA/CDER/OTS/OB
10:55 AM
Bayesian Statistical Methodologies for Evaluating Similarity in Exposure-Response Relationship Between Adults and Pediatrics
—
Mathangi Gopalakrishnan, Center for Translational Medicine, University of Maryland, Baltimore
11:15 AM
Bayesian and Frequentist Partial Extrapolation Approaches in Organ Transplantation to Support the Pediatric Plan for European Health Authorities
—
Steffen Ballerstedt, Novartis Pharma AG ; Jennifer Ng, Novartis Pharmaceuticals Inc
11:35 AM
Using Bayesian Methods to Incorporate Historical Information on Control Rate and Treatment Effect: An HIV-Paediatric Trial
—
Clara Dominguez Islas, MRC Biostatistics Unit ; Nicky Best, GlaxoSmithKline ; Rebecca Turner, MRC Biostatistics Unit ; Naomi Givens, GlaxoSmithKline ; Rimgaile Urbaityte, GlaxoSmithKline ; Sophie Barthel, GlaxoSmithKline ; Adrian Mander, MRC Biostatistics Unit
11:55 AM
Discussant: Margaret Gamalo-Siebers, Eli Lilly
12:15 PM
Floor Discussion